CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

Lutetium Lu 177 Vipivotide Tetraxetan

Phase 2
Novartis AG (NVS)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
NVSPhase 2

Lutetium Lu 177 Vipivotide Tetraxetan Phase 2 Est. Readout

Lutetium Lu 177 Vipivotide Tetraxetan
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Prostate Carcinoma

View Full Landscape
Drug Information

Target Indication

Prostate Carcinoma

Clinical Trial

NCT06216249

Last updated: 8/29/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.